| Literature DB >> 24940081 |
Tefera Gezmu1, Dona Schneider1, Kitaw Demissie2, Yong Lin2, Christine Giordano3, Martin S Gizzi4.
Abstract
Evidence implicates lipid abnormalities as important but modifiable risk factors for stroke. This study assesses whether hypercholesterolemia can be used to predict the risk for etiologic subtypes of ischemic stroke between sexes within racial/ethnic groups. Data elements related to stroke risk, diagnosis, and outcomes were abstracted from the medical records of 3,290 acute stroke admissions between 2006 and 2010 at a regional stroke center. Sex comparison within racial/ethnic groups revealed that South Asian and Hispanic men had a higher proportion of ischemic stroke than women, while the inverse was true for Whites and African Americans (P=0.0014). All women, except South Asian women, had higher mean plasma total cholesterol and higher blood circulating low-density lipoprotein levels (≥100 mg/dL) than men at the time of their admissions. The incidence of large-artery atherosclerosis (LAA) was more common among women than men, except among Hispanics, where men tended to have higher incidences. A regression analysis that considered patients diagnosed with either LAA or small-artery occlusion etiologic subtype as the outcomes and high-density lipoproteins and triglycerides as predictors showed inconsistent associations between lipid profiles and the incidence of these subtypes between the sexes within racial/ethnic groups. In conclusion, our investigation suggests that women stroke patients may be at increased risk for stroke etiologic subtype LAA than men. Although the higher prevalence of stroke risk factors examined in this study predicts the increase in the incidence of the disease, lack of knowledge/awareness and lack of affordable treatments for stroke risk factors among women and immigrants/non-US-born subpopulations may explain the observed associations.Entities:
Keywords: cerebrovascular disease; comorbidities; ischemic stroke; race/ethnicity; risk factors; sex
Year: 2014 PMID: 24940081 PMCID: PMC4051728 DOI: 10.2147/IJWH.S61274
Source DB: PubMed Journal: Int J Womens Health ISSN: 1179-1411
Characteristics of patients with acute stroke on admission, by sex within racial/ethnic groups
| Characteristic | Race/ethnicity
| |||
|---|---|---|---|---|
| White | African American | South Asian | Hispanic | |
| Female, % | 55.0 | 59.7 | 40.7 | 46.9 |
| Mean age in years (± SD) | ||||
| Male | 70.3 (14.2) | 64.3 (13.2) | 64.5 (13.8) | 62.8 (14.7) |
| Female | 75.3 (14.2) | 64.9 (15.4) | 66.0 (15.6) | 65.1 (17.4) |
| | <0.0001 | NS | NS | NS |
| Mean TC in mg/dL (± SD) | ||||
| Male | 165.2 (42.9) | 166.6 (48.3) | 172.8 (44.2) | 171.2 (54.3) |
| Female | 176.9 (45.2) | 184.7 (45.2) | 171.5 (46.1) | 183.1 (45.0) |
| | <0.0001 | <0.0001 | NS | NS |
| Mean HDL in mg/dL (± SD) | ||||
| Male | 39.6 (11.3) | 40.7 (14.4) | 39.4 (11.6) | 38.3 (11.5) |
| Female | 46.6 (14.6) | 48.1 (15.0) | 44.5 (11.8) | 43.7 (10.4) |
| | <0.0001 | <0.0001 | 0.0010 | 0.0006 |
| Mean LDL in mg/dL (± SD) | ||||
| Male | 101.8 (37.1) | 103.1 (38.3) | 108.4 (37.4) | 110.4 (44.3) |
| Female | 106.1 (39.6) | 115.9 (38.5) | 101.5 (39.1) | 112.1 (36.1) |
| | 0.0177 | 0.0006 | NS | NS |
| Mean systolic blood pressure in mmHg (± SD) | ||||
| Male | 150.1 (28.3) | 153.5 (32.2) | 153.8 (31.9) | 149.6 (27.6) |
| Female | 154.8 (32.1) | 154.0 (32.1) | 161.6 (33.3) | 154.1 (28.8) |
| | 0.0006 | NS | NS | NS |
| Mean diastolic blood pressure in mmHg (± SD) | ||||
| Male | 83.1 (17.8) | 87.3 (21.2) | 87.1 (18.1) | 83.3 (16.3) |
| Female | 82.4 (19.4) | 85.4 (19.3) | 88.0 (25.2) | 82.5 (18.3) |
| Mean body mass index in kg/m2 (± SD) | ||||
| Male | 27.7 (5.5) | 28.0 (6.4) | 25.4 (4.3) | 27.9 (4.3) |
| Female | 27.1 (6.3) | 29.8 (7.5) | 26.5 (5.8) | 28.8 (7.0) |
| | 0.0059 | 0.0029 | NS | NS |
| Geometric mean fasting blood glucose in mg/dL (95% CI) | ||||
| Male | 125.0 (122.3–127.8) | 126.9 (120.7–133.5) | 126.5 (119.3–134.1) | 128.5 (120.4–137.2) |
| Female | 119.7 (117.4–121.9) | 126.5 (121.3–131.8) | 138.2 (127.6–149.8) | 128.5 (119.3–138.4) |
| Geometric mean HbA1c in % (95% CI) | ||||
| Male | 6.3 (6.2–6.4) | 6.5 (6.3–6.7) | 6.8 (6.5–7.0) | 6.4 (6.2–6.7) |
| Female | 6.2 (6.1–6.3) | 6.5 (6.4–6.7) | 6.9 (6.6–7.2) | 6.4 (6.1–6.6) |
| Geometric mean triglycerides in mg/dL (95% CI) | ||||
| Male | 107.6 (103.9–111.3) | 92.9 (86.1–100.3) | 115.9 (106.3–126.4) | 107.9 (94.5–123.1) |
| Female | 107.4 (104.2–110.6) | 91.6 (86.5–97.0) | 115.6 (104.0–128.4) | 117.2 (106.3–129.2) |
Notes:
χ2 test P<0.0001.
Statistical test did not include missing values (~12%–17% for TC, LDL/HDL and 35% for HbA1c); also P-values for variables that were not statistically significantly different by sex are not shown.
Analysis of variance for comparing means.
Abbreviations: CI, confidence interval; HbA1c, glycated hemoglobin; HDL, high-density lipoprotein; LDL, low-density lipoprotein; NS, not significant at P=0.05 level; SD, standard deviation; TC, total cholesterol.
Percentage severity of hypercholesterolemia and lipid profiles for acute stroke patients, by sex within racial/ethnic groups
| Race/ethnicity (N=3,290)
| |||||
|---|---|---|---|---|---|
| White | African American | South Asian | Hispanic | ||
| Yes (n=1,346) | 47.9 | 57.9 | 52.8 | 56.2 | 0.0003 |
| Male | 42.6 | 36.2 | 63.6 | 48.7 | |
| Female | 57.4 | 63.8 | 36.4 | 51.3 | |
| No (n=1,299) | 52.1 | 42.1 | 47.2 | 43.8 | |
| | 0.0462 | 0.0111 | NS | NS | |
| Yes (n=1,394) | 45.0 | 37.3 | 37.5 | 38.3 | 0.0007 |
| Male | 48.3 | 43.1 | 61.8 | 53.1 | |
| Female | 51.7 | 56.9 | 38.2 | 46.9 | |
| No (n=1,890) | 55.0 | 62.8 | 62.5 | 61.7 | |
| | 0.0058 | NS | NS | NS | |
| Statin (n=1,852) | 55.0 | 60.5 | 65.6 | 59.2 | 0.0027 |
| Male | 47.4 | 40.2 | 64.5 | 56.7 | |
| Female | 52.6 | 59.8 | 35.5 | 43.3 | |
| | 0.0076 | NS | 0.0325 | NS | |
| Other medications | 1.2 | 0.8 | 0.4 | 1.2 | |
| Contraindicated | 5.4 | 3.8 | 4.0 | 7.0 | |
| None prescribed | 37.3 | 34.1 | 31.3 | 28.6 | |
Notes:
χ2 test for differences between racial/ethnic groups
19.6% data missing
χ2 test differences between the sexes within a racial/ethnic group
less than 0.2% (n=6) data missing
about 6% data missing.
Abbreviations: LDL-c, low-density lipoprotein cholesterol; NS, not significant at P<0.05 level.
Proportion of prescription medication use and the prevalence of most common stroke risk factors prior to admission, by sex within racial/ethnic groups
| Race/ethnicity
| ||||
|---|---|---|---|---|
| White | African American | South Asian | Hispanic | |
| Antihypertensive medications, % | ||||
| Male | 42.7 | 40.7 | 58.8 | 54.1 |
| Female | 57.3 | 59.3 | 41.2 | 45.9 |
| | 0.0003 | NS | NS | NS |
| Cholesterol-reducing medications, % | ||||
| Male | 48.3 | 43.1 | 61.8 | 53.1 |
| Female | 51.7 | 56.9 | 38.2 | 46.9 |
| | 0.0060 | NS | NS | NS |
| Antiplatelet medications, % | ||||
| Male | 45.1 | 38.8 | 63.4 | 57.6 |
| Female | 54.9 | 61.2 | 36.6 | 42.4 |
| Anticoagulant medications, % | ||||
| Male | 44.9 | 41.0 | 63.5 | 41.7 |
| Female | 55.1 | 59.0 | 36.5 | 58.3 |
| | NS | NS | NS | 0.0216 |
| Diabetic medications, % | ||||
| Male | 47.2 | 39.9 | 61.1 | 54.3 |
| Female | 52.8 | 60.1 | 38.9 | 45.7 |
| Hypertension, % | ||||
| Male | 43.8 | 40.5 | 58.3 | 53.6 |
| Female | 56.2 | 59.5 | 41.7 | 46.4 |
| | 0.0362 | NS | NS | NS |
| Diabetes mellitus, % | ||||
| Male | 48.7 | 41.2 | 57.3 | 50.6 |
| Female | 51.4 | 58.8 | 42.7 | 49.4 |
| | 0.0287 | NS | NS | NS |
| Cardiac disease, % | ||||
| Male | 47.0 | 43.8 | 68.7 | 59.7 |
| Female | 53.0 | 56.2 | 31.3 | 40.3 |
| Dyslipidemia, % | ||||
| Male | 48.0 | 38.2 | 65.0 | 50.0 |
| Female | 52.0 | 61.8 | 35.0 | 50.0 |
| | 0.0374 | NS | NS | NS |
| Smoking history, % | ||||
| Male | 58.0 | 55.9 | 92.0 | 76.2 |
| Female | 42.0 | 44.1 | 8.0 | 23.8 |
| | <0.0001 | 0.0009 | 0.0005 | 0.0271 |
| Previous stroke/TIA | ||||
| Male | 47.5 | 39.0 | 61.2 | 50.7 |
| Female | 52.5 | 61.0 | 38.2 | 49.3 |
| Any combination | ||||
| Male | 41.9 | 41.6 | 56.0 | 54.3 |
| Female | 58.1 | 58.4 | 44.0 | 45.7 |
| | 0.0045 | NS | NS | NS |
Notes:
χ2 test for differences between racial/ethnic groups
if P-values for statistical test were entirely not statistically significantly different by sex within racial/ethnic groups they were omitted from the table
cardiac disease includes atrial fibrillation, prost heart valve, coronary artery disease/prior myocardial infarction, carotid stenosis, peripheral vascular diseases, and heart failure
TIA duration <24 hours
any combination of these risk factors.
Abbreviations: NS, not significant at P<0.05 level; prost, prosthetic; TIA, transient ischemic attack.
Percentages of clinical diagnosis related to acute stroke, by sex within racial/ethnic groupsa
| Diagnosis | Race/ethnicity | |||
|---|---|---|---|---|
| White | African American | South Asian | Hispanic | |
| Ischemic stroke (n=1,541) | ||||
| Male | 44.0 | 40.4 | 58.8 | 52.4 |
| Female | 56.0 | 59.6 | 41.2 | 47.6 |
| Large artery atherosclerosis (n=360) | ||||
| Male | 42.3 | 48.3 | 44.4 | 56.3 |
| Female | 57.7 | 51.7 | 55.6 | 43.7 |
| Small artery occlusions (n=354) | ||||
| Male | 47.1 | 31.8 | 52.5 | 44.0 |
| Female | 52.9 | 68.2 | 47.5 | 56.0 |
| Cardioembolism (n=261) | ||||
| Male | 43.5 | 61.8 | 81.8 | 50.0 |
| Female | 56.5 | 38.2 | 18.2 | 50.0 |
| Stroke of other determined and undetermined causes (n=547) | ||||
| Male | 42.8 | 36.3 | 68.8 | 55.2 |
| Female | 57.2 | 65.7 | 31.3 | 44.8 |
| TIA | ||||
| Male | 44.5 | 35.8 | 61.5 | 51.1 |
| Female | 55.5 | 64.2 | 38.5 | 48.9 |
| Subarachnoid hemorrhage (n=129) | ||||
| Male | 36.6 | 44.0 | 50.0 | 57.1 |
| Female | 63.4 | 56.0 | 50.0 | 42.9 |
| Intracerebral hemorrhage (n=380) | ||||
| Male | 52.2 | 54.2 | 58.3 | 55.9 |
| Female | 47.8 | 45.8 | 41.7 | 44.1 |
| Stroke not otherwise specified (n=23) | ||||
| Male | 42.9 | 50.0 | 100.0 | 100.0 |
| Female | 57.1 | 50.0 | 0.0 | 0.0 |
| No stroke-related diagnosis (n=21) | ||||
| Male | 75.0 | 0.0 | 50.0 | 75.0 |
| Female | 25.0 | 100.0 | 50.0 | 25.0 |
Notes:
Less than 0.5% of data was missing
χ2 test for differences between sexes within a racial/ethnic group
ischemic stroke subtyping, based on classification scheme from the Trial of ORG 10172 in Acute Stroke Treatment (TOAST)
approximately 1.2% of the data of ischemic stroke patients lacked subtyping information
TIA duration <24 hours.
Abbreviation: TIA, transient ischemic attack.
Relative risk, stroke risk factors as predictors of ischemic stroke subtypes,a by sex within racial/ethnic groups
| Variable | Relative risk (95% CI)
| |||
|---|---|---|---|---|
| White | African American | South Asian | Hispanic | |
| Age (per 10 years) | ||||
| Male | 0.98 (0.87–1.11) | 1.22 (1.05–1.41) | 0.83 (0.58–1.17) | 1.13 (0.86–1.49) |
| Female | 1.20 (1.06–1.37) | 0.98 (0.76–1.26) | 1.27 (1.02–1.58) | 1.20 (0.93–1.55) |
| Smoking (Yes =1, No =0) | ||||
| Male | 1.03 (0.73–1.46) | 0.98 (0.51–1.88) | – | – |
| Female | 1.82 (1.36–2.45) | 1.01 (0.33–3.15) | – | – |
| HDL (per 10 mg/dL) | ||||
| Male | 0.91 (0.78–1.05) | 0.75 (0.61–0.93) | 0.62 (0.35–1.09) | 1.09 (0.92–1.30) |
| Female | 0.88 (0.80–0.96) | 1.06 (0.95–1.18) | 0.93 (0.74–1.18) | 1.01 (0.73–1.40) |
| Triglycerides (per 10 mg/dL) | ||||
| Male | 0.99 (0.97–1.01) | 0.94 (0.88–1.00) | 0.98 (0.93–1.04) | 1.01 (0.97–1.05) |
| Female | 0.97 (0.95–1.00) | 0.99 (0.94–1.05) | 1.01 (0.99–1.02) | 0.99 (0.93–1.04) |
Notes:
Ischemic stroke subtyping based on classification scheme from the Trial of ORG 10172 in Acute Stroke Treatment (TOAST)
due to the absence of women smokers in a dataset for South Asians, no comparison was done
regression equation did not converge when smoking was included in the variable, small sample size-smoking was not included in the analysis.
Abbreviations: CI, confidence interval; HDL, high-density lipoprotein.
Category of clinical characteristic measures on admission, by sex within racial/ethnic groups, in percentages
| Sex
| ||||||||
|---|---|---|---|---|---|---|---|---|
| Male
| Female
| |||||||
| Race/ethnicity
| Race/ethnicity
| |||||||
| White | African American | South Asian | Hispanic | White | African American | South Asian | Hispanic | |
| TC, % | ||||||||
| Desirable (TC <200 mg/dL) | 67.4 | 66.4 | 68.5 | 57.4 | 61.4 | 57.3 | 68.5 | 57.5 |
| Borderline high (TC 200–239 mg/dL) | 10.8 | 14.3 | 13.0 | 11.8 | 14.5 | 19.1 | 10.8 | 19.2 |
| High (TC >240 mg/dL) | 5.1 | 5.0 | 6.8 | 7.3 | 6.8 | 9.4 | 7.2 | 9.2 |
| Missing | 16.7 | 14.3 | 11.7 | 23.5 | 17.4 | 14.1 | 13.5 | 14.2 |
| LDL, % | ||||||||
| Near/above optimal (LDL <129 mg/dL) | 66.5 | 66.4 | 64.2 | 56.6 | 64.5 | 60.1 | 70.3 | 61.6 |
| Borderline high (LDL 130–159 mg/dL) | 11.1 | 13.5 | 16.7 | 13.2 | 11.0 | 13.3 | 9.9 | 14.2 |
| High (LDL 160–189 mg/dL) | 4.6 | 5.7 | 6.2 | 5.9 | 5.2 | 10.2 | 2.7 | 7.5 |
| Very high (LDL ≥190 mg/dL) | 2.0 | 1.6 | 1.8 | 2.2 | 2.4 | 2.5 | 4.5 | 2.5 |
| Missing | 15.8 | 12.7 | 11.1 | 22.1 | 16.9 | 13.9 | 12.6 | 14.2 |
| HDL, % | ||||||||
| Low (HDL <40 mg/dL) | 46.1 | 43.9 | 54.3 | 44.9 | 27.9 | 24.1 | 30.6 | 34.2 |
| Mid-range (40 mg/dl ≤ HDL <60 mg/dL) | 32.5 | 34.8 | 30.9 | 27.2 | 40.5 | 46.3 | 46.0 | 45.8 |
| High (HDL ≥60 mg/dL) | 4.5 | 7.4 | 3.1 | 4.4 | 14.1 | 15.5 | 9.9 | 5.8 |
| Missing | 16.8 | 13.9 | 11.7 | 23.5 | 17.5 | 14.1 | 13.5 | 14.2 |
| TG, % | ||||||||
| Normal (TG <150 mg/dL) | 62.9 | 71.7 | 61.7 | 58.1 | 63.7 | 73.4 | 55.9 | 63.3 |
| Borderline high (TG 150–199 mg/dL) | 12.5 | 9.8 | 14.2 | 8.8 | 12.2 | 8.3 | 19.8 | 9.2 |
| High (TG 200–499 mg/dL) | 7.4 | 4.5 | 12.4 | 8.8 | 6.3 | 4.4 | 9.9 | 12.5 |
| Very high (TG ≥500 mg/dL) | 0.4 | 0.4 | 0.6 | 0.7 | 0.3 | 0.0 | 0.9 | 0.8 |
| Missing | 16.8 | 13.5 | 11.1 | 23.5 | 17.5 | 13.9 | 13.5 | 14.2 |
| Blood Pressure Classification, % | ||||||||
| Normal (≤120/80 mmHg) | 42.5 | 31.2 | 34.6 | 38.2 | 43.8 | 37.1 | 36.0 | 42.5 |
| Prehypertension (120–139/80–89 mmHg) | 20.7 | 22.5 | 26.5 | 27.9 | 20.8 | 21.6 | 18.0 | 20.8 |
| Stage 1 hypertension (140–159/90–99 mmHg) | 19.0 | 20.5 | 14.8 | 14.0 | 15.0 | 16.3 | 18.0 | 11.7 |
| Stage 2 hypertension (>160/100 mmHg) | 11.4 | 18.9 | 19.8 | 10.3 | 13.0 | 14.4 | 18.0 | 16.7 |
| Missing | 6.4 | 7.0 | 4.3 | 9.6 | 7.4 | 10.5 | 9.9 | 8.3 |
| Blood glucose classification, % | ||||||||
| FBG <126 mm/dL | 54.1 | 49.2 | 58.0 | 46.3 | 57.0 | 50.4 | 41.4 | 51.7 |
| FBG ≥126 mm/dL | 35.0 | 40.2 | 35.8 | 41.2 | 31.1 | 35.7 | 46.0 | 38.3 |
| Missing | 10.9 | 10.6 | 6.2 | 12.5 | 11.7 | 13.9 | 12.6 | 10.0 |
| HbA1c classifications, % | ||||||||
| HbA1c <6.5% | 44.0 | 39.3 | 38.3 | 39.0 | 44.8 | 37.1 | 29.7 | 42.5 |
| HbA1c ≥6.5% | 19.3 | 27.1 | 32.7 | 27.2 | 16.5 | 30.2 | 43.2 | 21.7 |
| Missing | 36.8 | 33.6 | 29.0 | 33.8 | 38.7 | 32.7 | 27.0 | 35.8 |
| BMI, % | ||||||||
| Underweight (BMI ≤18.5 kg/m2) | 0.5 | 1.6 | 1.9 | 0.0 | 3.6 | 2.5 | 4.5 | 2.5 |
| Normal (BMI <24.9 kg/m2) | 29.2 | 29.2 | 49.4 | 25.0 | 35.1 | 20.2 | 36.0 | 23.3 |
| Overweight (25.0< BMI <29.9 kg/m2) | 36.1 | 32.8 | 29.6 | 41.9 | 27.1 | 28.8 | 24.3 | 33.3 |
| Obese (BMI ≥30.0 kg/m2) | 24.1 | 25.8 | 14.8 | 22.8 | 22.1 | 33.8 | 19.8 | 30.8 |
| Missing | 10.1 | 9.8 | 4.3 | 10.3 | 12.1 | 14.7 | 15.3 | 10.0 |
Notes:
Blood pressure level based on the seventh report of the Joint National Committee on Hypertension, (JNC7)
classification based on the criteria for diagnosis of diabetes by the American Diabetes Association, 2010
BMI based on the Centers for Disease Control and Prevention BMI guidelines for weight status.
Abbreviations: BMI, body mass index; FBG, fasting blood glucose; HbA1c, glycated hemoglobin; HDL, high-density lipoprotein; LDL, low-density lipoprotein; TC, total cholesterol; TG, triglycerides.